Join BOPA
Back to news articles

A 3rd Cohort is Coming – BOPA Introduction to Oncology 2023!

By BOPA Committee on 12th May 2023

BOPA is delighted to announce that a 3rd cohort of the popular Introduction to Oncology course will be held in London in November 2023!

 

Information for date and venue to be confirmed in July!

 

The BOPA Introduction to Oncology has been overwhelmingly popular. Places for the London cohort (June 2023) were all taken up with the first hours of registration opening. The waiting list is now closed to requests.

Due to the huge demands, BOPA has confirmed that a 3rd cohort of the Introduction to Oncology course will take place in London in November 2023!

More info to follow. Look out for announcement on BOPA website and our social media platforms.

Visit the dedicated BOPA ITO page here: https://www.bopa.org.uk/intro_to_onc_2023/

The BOPA Education and Training Subcommittee

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article